PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 201 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,344,000 | +1338.7% | 574,974 | +469.8% | 0.01% | +500.0% |
| Q1 2020 | $719,000 | -70.7% | 100,900 | -1.7% | 0.00% | 0.0% |
| Q4 2019 | $2,450,000 | -4.4% | 102,600 | +7.3% | 0.00% | -50.0% |
| Q3 2019 | $2,564,000 | +0.7% | 95,600 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $2,545,000 | -21.8% | 93,800 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $3,255,000 | +79.0% | 93,800 | +0.7% | 0.00% | +100.0% |
| Q4 2018 | $1,818,000 | -27.7% | 93,135 | -1.3% | 0.00% | -50.0% |
| Q3 2018 | $2,513,000 | -29.5% | 94,360 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,564,000 | -58.2% | 94,360 | -63.9% | 0.00% | -66.7% |
| Q1 2018 | $8,536,000 | +129.6% | 261,360 | +242.3% | 0.01% | +100.0% |
| Q4 2017 | $3,717,000 | -32.8% | 76,360 | -25.4% | 0.00% | -25.0% |
| Q3 2017 | $5,531,000 | -6.3% | 102,370 | -2.6% | 0.00% | -20.0% |
| Q2 2017 | $5,906,000 | -59.4% | 105,150 | -71.7% | 0.01% | -58.3% |
| Q1 2017 | $14,554,000 | +89.5% | 371,373 | +8.5% | 0.01% | +100.0% |
| Q4 2016 | $7,681,000 | -1.2% | 342,283 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $7,773,000 | -3.8% | 342,283 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $8,078,000 | +15.7% | 342,283 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $6,983,000 | -60.3% | 342,283 | 0.0% | 0.01% | -60.0% |
| Q4 2015 | $17,610,000 | +20.7% | 342,283 | -0.0% | 0.02% | +15.4% |
| Q3 2015 | $14,589,000 | -6.3% | 342,298 | +0.1% | 0.01% | 0.0% |
| Q2 2015 | $15,570,000 | +24.1% | 341,823 | +3.4% | 0.01% | +30.0% |
| Q1 2015 | $12,550,000 | +35.6% | 330,623 | +1.2% | 0.01% | +25.0% |
| Q4 2014 | $9,256,000 | +12.0% | 326,823 | 0.0% | 0.01% | +14.3% |
| Q3 2014 | $8,262,000 | -20.0% | 326,823 | -7.6% | 0.01% | -22.2% |
| Q2 2014 | $10,322,000 | +17.4% | 353,723 | +4.2% | 0.01% | +12.5% |
| Q1 2014 | $8,789,000 | -57.0% | 339,357 | -57.2% | 0.01% | -55.6% |
| Q4 2013 | $20,416,000 | +3413.9% | 792,857 | +3548.0% | 0.02% | +1700.0% |
| Q3 2013 | $581,000 | +110.5% | 21,734 | +93.3% | 0.00% | – |
| Q2 2013 | $276,000 | – | 11,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |